Hak-Hyun Nam
Founder at I-SENS, INC.
Net worth: 26 M $ as of 30/05/2024
Profile
Hak-Hyun Nam is the founder of i-SENS, Inc. which was founded in 2000.
She is currently a Non-Executive Director at Precision Biosensor, Inc., a Director at I Sense Jiangsu Co., Ltd., and a Director at CoaguSense, Inc. Dr. Nam holds a doctorate degree from Michigan State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
I-SENS, INC.
7.20% | 03/06/2024 | 1,990,000 ( 7.20% ) | 25 M $ | 30/05/2024 |
| 29/06/2023 | 100,000 ( 0.86% ) | 312 737 $ | 30/05/2024 |
Hak-Hyun Nam active positions
| Companies | Position | Start |
|---|---|---|
| I-SENS, INC. | Founder | 03/05/2000 |
| PRECISION BIOSENSOR, INC. | Director/Board Member | - |
| I Sense Jiangsu Co., Ltd. | Director/Board Member | - |
CoaguSense, Inc.
 CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Director/Board Member | - |
Training of Hak-Hyun Nam
| Michigan State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| I-SENS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Precision Biosensor, Inc. | |
| I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
- Stock Market
- Insiders
- Hak-Hyun Nam
